Conolidine’s analgesic effects stem from its conversation with non-opioid pain pathways. Not like opioids, which bind to µ-opioid receptors while in the central anxious procedure, conolidine modulates alternate molecular targets. A Science Innovations examine uncovered that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR